Parameter
| Biomarker | GFAP | Full name | Glial fibrillary acidic protein | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Susceptibility, early diagnosis | ||
| Disease | Liver Cirrhosis | Disease Subtypes | / | ||
| Organ | Liver | Test Sample / Technology Platform | Plasma (SIMOA) | ||
| Pathobiological Mechanisms | A sign of astrocyte activation. In AD, they may be activated early in the pathological response to Aβ. | ||||
| Clinical Availability Status | Frontier research: a large amount of evidence shows that it changes in the presymptomatic stage and is a potential risk warning marker. | ||||
| Notes and Dynamics | It is highly correlated with Aβ pathology and may reflect changes in the brain earlier than p-tau. | ||||